Morning Technical Breakdown Highlights on Big Drug Makers’ Stocks

LONDON, UK / ACCESSWIRE / May 27, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Pfizer, Merck & Co., Johnson & Johnson, and AbbVie. 

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/register/.

Soaring drug prices remain to be one of the biggest challenges faced by the Major Drug Manufacturers industry, but several companies seem unaffected by the cost pressures and are even performing consistently well. Let us see how this is affecting some of the big names in the industry. Sign up now for your free technical alerts at:

http://www.activewallst.com/register/

ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Pfizer Inc. (NYSE: PFE)

New York-based biopharmaceutical Company, Pfizer Inc.’s stock finished Thursday’s session 0.23% higher at $34.43 with a total volume of 25.25 million shares traded. The Company’s shares have advanced 5.27% in the past month, 14.91% over the previous three months, and 8.70% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 7.46% and 8.92%, respectively. Furthermore, shares of Pfizer have a Relative Strength Index (RSI) of 73.65. On May 12th, 2016, research firm Berenberg initiated a ‘Hold’ rating, issuing a target price of $38 on the Company’s stock.

Merck & Co. Inc. (NYSE: MRK)

On Thursday, shares in global health care solutions provider, Merck & Co. Inc., ended the session at $56.39, which was a slight correction of 0.32%. The stock recorded a trading volume of 5.70 million shares. The Company’s shares have gained 0.14% in the last one month, 12.33% in the previous three months, and 7.69% since the start of this year. The stock is trading 3.11% above its 50-day moving average and 7.56% above its 200-day moving average. Moreover, shares of Merck & Co. have an RSI of 63.29.

Johnson & Johnson (NYSE: JNJ)

Johnson & Johnson, in conjunction with its subsidiaries, researches and develops, produces, and sells an assortment of health care products globally. The Company’s stock ended yesterday’s session at $112.90, which was a slight correction of 0.40%, and with a total volume of 3.97 million shares traded. The Company’s shares have advanced 0.83% in the past month, 7.49% in the previous three months, and 11.50% on an YTD basis. The stock is trading 2.23% above its 50-day moving average and 11.59% above its 200-day moving average. Additionally, shares of Johnson & Johnson have an RSI of 55.84. On May 20th, 2016, research firm Standpoint Research initiated a ‘Sell’ rating, issuing a target price of $94 on the Company’s stock.

AbbVie Inc. (NYSE: ABBV)

At the close on Thursday, shares in global pharmaceutical products manufacturer, AbbVie Inc., recorded a trading volume of 6.53 million shares. The stock finished 1.11% higher at $61.90. The Company’s shares have gained 1.98% in the last one month, 11.60% over the previous three months, and 6.60% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 4.01% and 7.76%, respectively. Furthermore, shares of AbbVie have an RSI of 57.54. The complete trade setup on ABBV is available for free at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440474